THE NOVEL CALCIUM-ANTAGONIST RO-40-5967 LIMITS MYOCARDIAL INFARCT SIZE IN THE DOG

被引:39
作者
HEIDE, RSV [1 ]
SCHWARTZ, LM [1 ]
REIMER, KA [1 ]
机构
[1] DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710
关键词
CALCIUM ANTAGONISTS; VERAPAMIL; RO; 40-5967; ISCHEMIC PRECONDITIONING; MYOCARDIAL INFARCT SIZE; MYOCARDIAL ISCHEMIA; REPERFUSION; REPERFUSION INJURY;
D O I
10.1093/cvr/28.10.1526
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim was to compare the infarct limiting effect of Ro 40-5967 (Ro40), a new calcium antagonist with little negative inotropic activity, with that of verapamil and with ischaemic preconditioning, a potent endogenous cardioprotective mechanism. Methods: Dogs (n=53) of either sex were subjected to 60 min of coronary occlusion followed by 3 h of reperfusion. Drug treated dogs received either verapamil (1.0 mg.kg(-1)) or Ro40 (3.0 mg.kg(-1)) intravenously for 100 min starting 15 min prior to the occlusion. Control dogs received a saline infusion. Ischaemic preconditioning consisted of four 5 min cycles of ischaemia alternating with four 5 min cycles of reperfusion. After 3 h of reflow, hearts were excised and infarct size was measured using tripheyltetrazolium chloride macrochemistry and expressed as percent of the ischaemic area at risk (AAR). To control for variation in infarct size due to variation in collateral blood flow, infarct size among groups was compared using ANCOVA, in which infarct size and collateral blood flow, measured at 30 min of occlusion, were dependent and independent variables, respectively. Results: Transmural collateral blood flow and AAR were not significantly different between any of the groups. Mean infarct size (adjusted by ANCOVA for slight differences in collateral blood flow among groups) in control dogs (n=13) was 25.9(SEM 3.2)% of the AAR. Both verapamil (n = 11) and Ro40 (n = 9) limited infarct size [14.2(3.2)% AAR and 16.7(2.9)% AAR, respectively; both p < 0.05]. Preconditioning (n = 17) also significantly limited infarct size [8.1(1.8)%; p < 0.01]. Conclusions: The new calcium antagonist, Ro 40-5967, was as effective as verapamil in limiting Infarct size after 60 min of regional ischaemia followed by 3 h of reperfusion, although neither calcium antagonist was as effective as ischaemic preconditioning.
引用
收藏
页码:1526 / 1532
页数:7
相关论文
共 30 条
[1]  
ALPS BJ, 1983, ARZNEIMITTELFORSCH, V33-1, P868
[2]   RO 40-5967, A NOVEL CALCIUM-CHANNEL ANTAGONIST, PROTECTS AGAINST VENTRICULAR-FIBRILLATION [J].
BILLMAN, GE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 229 (2-3) :179-187
[3]   THE STRUCTURALLY NOVEL CA-2+ CHANNEL BLOCKER RO 40-5967, WHICH BINDS TO THE [H-3] DESMETHOXYVERAPAMIL RECEPTOR, IS DEVOID OF THE NEGATIVE INOTROPIC EFFECTS OF VERAPAMIL IN NORMAL AND FAILING RAT HEARTS [J].
CLOZEL, JP ;
VENIANT, M ;
OSTERRIEDER, W .
CARDIOVASCULAR DRUGS AND THERAPY, 1990, 4 (03) :731-736
[4]   AUTORADIOGRAPHIC METHOD FOR MEASURING THE ISCHEMIC MYOCARDIUM AT RISK - EFFECTS OF VERAPAMIL ON INFARCT SIZE AFTER EXPERIMENTAL CORONARY-ARTERY OCCLUSION [J].
DEBOER, LWV ;
STRAUSS, HW ;
KLONER, RA ;
RUDE, RE ;
DAVIS, RF ;
MAROKO, PR ;
BRAUNWALD, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (10) :6119-6123
[5]   A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY TO COMPARE THE EFFICACY AND SAFETY OF CHRONIC NIFEDIPINE THERAPY WITH THAT OF ISOSORBIDE DINITRATE AND THEIR COMBINATION IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE [J].
ELKAYAM, U ;
AMIN, J ;
MEHRA, A ;
VASQUEZ, J ;
WEBER, L ;
RAHIMTOOLA, SH .
CIRCULATION, 1990, 82 (06) :1954-1961
[6]   DILTIAZEM INCREASES LATE-ONSET CONGESTIVE-HEART-FAILURE IN POSTINFARCTION PATIENTS WITH EARLY REDUCTION IN EJECTION FRACTION [J].
GOLDSTEIN, RE ;
BOCCUZZI, SJ ;
CRUESS, D ;
NATTEL, S .
CIRCULATION, 1991, 83 (01) :52-60
[7]  
HANSEN JF, 1991, CARDIOVASC DRUG THER, V5, P665
[8]   CALCIUM-CHANNEL BLOCKERS IN ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA - AN OVERVIEW [J].
HELD, PH ;
YUSUF, S ;
FURBERG, CD .
BMJ-BRITISH MEDICAL JOURNAL, 1989, 299 (6709) :1187-1192
[9]   EFFECTS OF NIFEDIPINE ON MYOCARDIAL PERFUSION AND ISCHEMIC-INJURY IN DOGS [J].
HENRY, PD ;
SHUCHLEIB, R ;
BORDA, LJ ;
ROBERTS, R ;
WILLIAMSON, JR ;
SOBEL, BE .
CIRCULATION RESEARCH, 1978, 43 (03) :372-380
[10]  
HIGGINSON L, 1991, J AM COLL CARDIOL, V18, P867